Pharmafile Logo
Pharmafocus logo
Advanced Search
zeiss_microscopy

Scientists prevent axon self-destruct mechanism using gene therapy

January 17, 2019
Research and Development Axon, gene therapy, health, neuropathy

Scientists at the University of Washington have developed a gene therapy that prevents the process through which axons (nerve fibres) …

News

Eli Lilly’s Verzenios scores NICE recommendation for advanced breast cancer

January 17, 2019
Sales and Marketing Cancer, Eli Lilly, NICE, Verzenios, breast cancer, pharma

Breast cancer patients in England and Wales now have access to another treatment option, as NICE announces its recommendation of …

News

More young people surviving cancer in England, despite significant economic divide

January 17, 2019
Medical Communications, Research and Development Cancer, England, UK, health public health, oncology, young people

Mortality and five year survival rates in a range of different cancers among people aged 13-24 improved in England between …

News
abbottweb

Abbott to boost heart valve therapy portfolio with acquisition of Cephea Valve Technologies

January 17, 2019
Manufacturing and Production, Sales and Marketing Abbott, Cephea, acquistion, mitral valve disease, pharma

As mergers and acquisitions pick up again for the New Year, Abbott has revealed plans to buy medical device firm …

News
920x920

Sacklers accused of personally directing deceptive OxyContin sales tactics

January 17, 2019
Sales and Marketing OxyContin, Purdue Pharma, opidois, opioid crisis, pain, sackler

Members of the billionaire Sackler dynasty personally directed efforts to mislead doctors and patients as to the dangers of the …

News
16792957331_d9572dbdf4_z

US regulator to recruit 50 new gene and cell therapy clinical reviewers

January 16, 2019
Research and Development FDA, cell therapy, gene therapy, regulation

FDA Commissioner Scott Gottlieb has said that the agency hopes to recruit 50 additional clinical reviewers for the group that …

News
merckincweb1

MSD’s Keytruda boosts overall survival by 31% in advanced oesophageal cancer

January 16, 2019
Research and Development Cancer, MSD, keytruda, oesophageal cancer, pharma

MSD has unveiled new Phase 3 data for its blockbuster anti-PD-1 immunotherapy Keytruda (pembrolizumab), showing that the drug succeeded in …

News

Breast cancer cells can be transformed into fat cells using combination therapy, study shows

January 16, 2019
Research and Development Cancer, EMT, breast cancer, cells, oncology, tumours

An innovative cancer treatment can turn malignant breast cancer cells into fat cells, thus preventing the formation of metastases (the …

News
novo_flag

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for eleven markets in Asia Pacific

January 16, 2019
Manufacturing and Production, Medical Communications, Research and Development DKSH, Novo Nordisk, pharma

DKSH’s Business Unit Performance Materials, a leading ingredients and specialty chemicals distributor, will distribute Novo Nordisk Pharmatech’s pharmaceutical grade compounds …

News
5204602349_c87b204860_z

FDA halts allergy drug approval process due to government shutdown

January 15, 2019
Research and Development Aimmune, FDA, Trump, governmetn, shutdown

California-based pharma firm, Aimunne Therapeutics has been notified that due to the government shutdown, the US Food and Drug Administration …

News
douglas_watson

Former CEO of Novartis’ US operations joins board of cancer immunotherapy firm

January 15, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

ImmunSYS, a Fort Lauderdale, Florida-based firm focused on the development of innovative cancer immunotherapy products, today announced that Douglas G …

Appointment

Tumours with large number of mutations respond better to immunotherapies, study shows

January 15, 2019
Manufacturing and Production, Research and Development Cancer, immunotherapy, nature, oncology, research, tumour

Tumours with a large number of DNA mutations are more likely to respond to immunotherapies than cancers with fewer mutations, …

News
shutterstock_212035546

Verona’s shares drop 34% on Phase 2 failure of nebulised ensifentrine in COPD

January 15, 2019
Manufacturing and Production, Research and Development Boehringer, COPD, Stiolto Respimat, pharma, trial failure, verona pharma

Verona Pharma has seen its shares crater following the Phase 2 failure of its nebulised ensifentrine, known as RPL554, in …

News
novartis_outside_1

Dutch health minister attacks Novartis over orphan drug price hike

January 15, 2019
Manufacturing and Production Cancer, Lutathera, NL, Netherlands, Novartis, oncology

Dutch health minister Bruno Bairns has called for a meeting with Swiss multinational Novartis after the multibillion-dollar firm introduced a …

News
perjeta-e1339339399552

Scotland recommends Roche’s Perjeta for HER2+ metastatic breast cancer

January 15, 2019
Manufacturing and Production, Sales and Marketing Breast cancer; Roche; Scotland, NHS, Perjeta, UK, pharma

Breast cancer patients in Scotland are set to receive an additional treatment option, as the Scottish Medicines Consortium announces its …

News
35482508871_5eabae9691_z

US Lawmaker launches investigation into pharma pricing practices

January 15, 2019
Manufacturing and Production Bernie Sanders, Elijah cummings, congress, pharma, pricing, us politics

Congressman Elijah Cummings has launched an investigation into pharmaceutical pricing practices.The representative for Maryland’s 7th congressional district, on Monday requested …

News
sean_bohen

AstraZeneca’s chief medical officer announces resignation amid wave of departures

January 14, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

AstraZeneca’s Sean Bohen has announced he will step down from his role as chief medical officer at the Anglo-Swedish drugmaker …

Appointment
nve00002_web

Living with Alström syndrome

January 14, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alström syndrome, patient experience, pharma, rare disease

Kay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of …

Feature
3-dimensional-model-of-influenza-virus-3d-graphical-representation-of-influenza-virion-ultrastructure-562x544

Seqirus secures first cell-based quadrivalent influenza vaccine approval in Europe

January 14, 2019
Sales and Marketing Europe, Flucelvax, flu, influenza, pharma, seqirus

Seqirus has made it known that its new cell-based seasonal influenza vaccine Flucelvax Tetra has been approved by the European …

News

Teva settles $135 million dollar fraud case over Medicaid price inflation

January 14, 2019
Sales and Marketing court, fraud, law, lawsuit, pharma, price fxing

Israeli multinational Teva Pharmaceuticals has agreed to pay $135 million after being accused of fraudulently inflating wholesale prices that went …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026